INTERPLAY OF EXERCISE AND DIABETES MEDICATION EFFECTS IN TYPE 2 DIABETES

While previous research has demonstrated the effect of various exercise modalities in improving HbA1c levels, little is known about how hypoglycemic medication usage influences chronic glucose control during exercise interventions. PURPOSE: The purpose of this study is to investigate the impact of hypoglycemic medications that can promote weight gain or weight loss on HbA1c improvement within three exercise training modalities: Aerobic (AT), Resistance (RT), and their Combination (CT). METHODS: Participants with type 2 diabetes (n = 212) took diabetic medications that have been shown to cause weight loss or weight gain. Based on the number of different medications taken, individuals were classified into weight Loss, Equal, and Gain groups. Each group was further divided into 9 months of non-exercise control (CON), AT, RT, or CT groups based on study randomization. The data were analyzed using a two-way analysis of covariance to examine the relationship between HbA1c changes and exercise modality across medication types, with baseline HbA1c as a covariate. RESULTS: Exercise modality and interaction between exercise modality and medication type showed significant effects on the change in HbA1c (p < 0.001, p = 0.029, p = 0.049, resp), whereas the main effect of medication type did not have an effect (p = 0.279). In the Lose medication group, the mean change in HbA1c increased in the CON group (0.57%; 95% CI, 0.09% to 1.05%) and decreased in the RT group (-0.35%; 95% CI, -0.69% to -0.02%). In the Equal medication group, the CT group showed a decrease in HbA1c level (-0.61%; 95% CI, -0.95% to -0.27%). In the Gain medication group, the AT group showed a decrease in HbA1c level (-0.71%; 95% CI, -1.29 to -0.13). These changes in HbA1c are likely moderated by changes in body composition (lean and fat mass). CONCLUSION: The medication group associated with weight loss suggests the potential for HbA1c reduction with resistance exercise. For patients with balanced medications, combination training could be effective, while aerobic training could be recommended for those on weight gain-related medication. These data suggest that training modality selection could be considered based on medication type.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2024-09-16
DOI
https://doi.org/10.1249/01.mss.0001053900.30484.46
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

INTERPLAY OF EXERCISE AND DIABETES MEDICATION EFFECTS IN TYPE 2 DIABETES

Guillaume Spielmann, Neil M. Johannsen, Timothy S. Church, Ginhyuk Kwon
Medicine & Science in Sports & Exercise
Pharmacology and Obesity Treatment
article

INTERPLAY OF EXERCISE AND DIABETES MEDICATION EFFECTS IN TYPE 2 DIABETES

Guillaume Spielmann, Neil M. Johannsen, Timothy S. Church, Ginhyuk Kwon
article en

Abstract

While previous research has demonstrated the effect of various exercise modalities in improving HbA1c levels, little is known about how hypoglycemic medication usage influences chronic glucose control during exercise interventions. PURPOSE: The purpose of this study is to investigate the impact of hypoglycemic medications that can promote weight gain or weight loss on HbA1c improvement within three exercise training modalities: Aerobic (AT), Resistance (RT), and their Combination (CT). METHODS: Participants with type 2 diabetes (n = 212) took diabetic medications that have been shown to cause weight loss or weight gain. Based on the number of different medications taken, individuals were classified into weight Loss, Equal, and Gain groups. Each group was further divided into 9 months of non-exercise control (CON), AT, RT, or CT groups based on study randomization. The data were analyzed using a two-way analysis of covariance to examine the relationship between HbA1c changes and exercise modality across medication types, with baseline HbA1c as a covariate. RESULTS: Exercise modality and interaction between exercise modality and medication type showed significant effects on the change in HbA1c (p < 0.001, p = 0.029, p = 0.049, resp), whereas the main effect of medication type did not have an effect (p = 0.279). In the Lose medication group, the mean change in HbA1c increased in the CON group (0.57%; 95% CI, 0.09% to 1.05%) and decreased in the RT group (-0.35%; 95% CI, -0.69% to -0.02%). In the Equal medication group, the CT group showed a decrease in HbA1c level (-0.61%; 95% CI, -0.95% to -0.27%). In the Gain medication group, the AT group showed a decrease in HbA1c level (-0.71%; 95% CI, -1.29 to -0.13). These changes in HbA1c are likely moderated by changes in body composition (lean and fat mass). CONCLUSION: The medication group associated with weight loss suggests the potential for HbA1c reduction with resistance exercise. For patients with balanced medications, combination training could be effective, while aerobic training could be recommended for those on weight gain-related medication. These data suggest that training modality selection could be considered based on medication type.

Medicine & Science in Sports & ExerciseVol. 56(10S)
University of Texas Health Science Center at Dallas (US)
Openalex Percentile: Top 85%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.